Found 4 matching trials
Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma PHASE2 This multicenter, single-arm, phase II study (FRONTIER) evaluates the effic...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study PHASE2 The aim of this clinical trial is to learn about efficacy of fruquintinib c...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Efficacy Study of Digoxin Combined With Serplulimab and Chemotherapy in First-Line Treatment of MSS Advanced Colorectal Cancer PHASE1 Efficacy Study of Digoxin Combined with Serplulimab and Chemotherapy in Fir...
Show More Location
Anyang Cancer Hospital
Learn More & Join Trial
Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma PHASE2 This study is testing a new treatment approach for people who have had surg...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial